Loading viewer...
investor_presentation
Format: PDF investor_presentation
Virpax Pharmaceuticals is developing innovative delivery platform technologies for non-addictive treatment options in pain and neurological disorders. The company collaborates with the NIH and DOD to create differentiated therapeutics targeting multi-billion-dollar markets. This investor presentation outlines the company's mission, strategy, and business objectives.
investor_presentation
29 Pages
investor_presentation
26 Pages
HNI Corporation
CIRCOR Q4 2016 Investor Review
investor_presentationinvestor_presentation
10 Pages
CIRCOR International